Antibody-Dependent Enhancement: ″Evil″ Antibodies Favorable for Viral Infections.
Fc receptors
antibody-dependent enhancement
immune responses
transcription modulation
virus entry
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
08 08 2022
08 08 2022
Historique:
received:
04
07
2022
revised:
03
08
2022
accepted:
05
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
30
8
2022
Statut:
epublish
Résumé
The pandemics caused by emerging viruses such as severe acute respiratory syndrome coronavirus 2 result in severe disruptions to public health. Vaccines and antibody drugs play essential roles in the control and prevention of emerging infectious diseases. However, in contrast with the neutralizing antibodies (NAbs), sub- or non-NAbs may facilitate the virus to enter the cells and enhance viral infection, which is termed antibody-dependent enhancement (ADE). The ADE of most virus infections is mediated by the Fc receptors (FcRs) expressed on the myeloid cells, while others are developed by other mechanisms, such as complement receptor-mediated ADE. In this review, we comprehensively analyzed the characteristics of the viruses inducing FcRs-mediated ADE and the new molecular mechanisms of ADE involved in the virus entry, immune response, and transcription modulation, which will provide insights into viral pathogenicity and the development of safer vaccines and effective antibody drugs against the emerging viruses inducing ADE.
Identifiants
pubmed: 36016361
pii: v14081739
doi: 10.3390/v14081739
pmc: PMC9412366
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Receptors, Fc
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Dev Comp Immunol. 2019 Jan;90:186-198
pubmed: 30273630
Virol Sin. 2018 Jun;33(3):249-260
pubmed: 29761267
J Virol. 1986 Mar;57(3):952-9
pubmed: 3951020
Front Immunol. 2021 Feb 24;12:640093
pubmed: 33717193
Immunol Rev. 2015 Nov;268(1):340-64
pubmed: 26497532
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Sci Rep. 2016 Jul 06;6:29201
pubmed: 27380892
Nat Rev Drug Discov. 2022 Jul 5;:
pubmed: 35790857
Lancet Infect Dis. 2010 Oct;10(10):712-22
pubmed: 20883967
J Exp Med. 1977 Jul 1;146(1):218-29
pubmed: 195000
J Gen Virol. 1985 Sep;66 ( Pt 9):1969-82
pubmed: 4031825
Viruses. 2022 Jan 11;14(1):
pubmed: 35062329
Virology. 2007 Jul 20;364(1):64-72
pubmed: 17382365
Comp Immunol Microbiol Infect Dis. 1981;4(2):175-89
pubmed: 6754243
Nat Immunol. 2015 Jul;16(7):785
pubmed: 26086146
Curr Opin Virol. 2017 Feb;22:89-96
pubmed: 28088123
Cell Host Microbe. 2007 Apr 19;1(2):135-45
pubmed: 18005691
J Exp Med. 2002 Sep 16;196(6):859-65
pubmed: 12235218
Med Microbiol Immunol. 2014 Apr;203(2):115-23
pubmed: 24337366
Nat Microbiol. 2020 Oct;5(10):1185-1191
pubmed: 32908214
Vaccine. 2009 Jun 8;27(28):3704-18
pubmed: 19464553
J Hepatol. 2017 Jun;66(6):1130-1137
pubmed: 28192188
Immunology. 2021 Oct;164(2):386-397
pubmed: 34056709
Curr Microbiol. 2021 Jan;78(1):17-32
pubmed: 33231723
Expert Rev Vaccines. 2018 Sep;17(9):785-795
pubmed: 30145912
Int J Biol Macromol. 2019 Oct 1;138:198-206
pubmed: 31284005
J Infect Dis. 2017 Mar 1;215(5):818-823
pubmed: 28011910
mBio. 2021 Oct 26;12(5):e0198721
pubmed: 34579572
Annu Rev Immunol. 2017 Apr 26;35:285-311
pubmed: 28446061
J Gen Virol. 1984 Aug;65 ( Pt 8):1261-72
pubmed: 6086817
J Gen Virol. 1996 Mar;77 ( Pt 3):407-11
pubmed: 8601774
Viruses. 2020 Feb 25;12(3):
pubmed: 32106567
Lancet. 2019 Jan 26;393(10169):350-363
pubmed: 30696575
Microbes Infect. 2020 Mar;22(2):72-73
pubmed: 32092539
J Gene Med. 2021 Feb;23(2):e3297
pubmed: 33217097
Biochem Biophys Res Commun. 2014 Aug 22;451(2):208-14
pubmed: 25073113
Front Immunol. 2017 Mar 21;8:317
pubmed: 28377769
Sci Immunol. 2017 Aug 18;2(14):
pubmed: 28821561
mBio. 2018 Oct 9;9(5):
pubmed: 30301856
PLoS Pathog. 2010 Jan;6(1):e1000718
pubmed: 20062797
Virol J. 2014 May 06;11:82
pubmed: 24885320
Microbes Infect. 2020 May - Jun;22(4-5):162-164
pubmed: 32442682
Science. 2010 May 7;328(5979):745-8
pubmed: 20448183
Adv Healthc Mater. 2021 Aug;10(15):e2002140
pubmed: 33929789
Expert Rev Vaccines. 2016 Sep;15(9):1123-34
pubmed: 26985862
Front Cell Infect Microbiol. 2020 Oct 02;10:580096
pubmed: 33123500
Front Cell Infect Microbiol. 2020 Oct 22;10:572681
pubmed: 33194810
J Immunol. 1993 Aug 1;151(3):1731-8
pubmed: 7687637
AIDS. 2018 Nov 13;32(17):2439-2451
pubmed: 30234611
PLoS Pathog. 2010 Feb 12;6(2):e1000790
pubmed: 20168989
J Mol Histol. 2017 Aug;48(4):301-310
pubmed: 28597201
PLoS Negl Trop Dis. 2015 Oct 05;9(10):e0004081
pubmed: 26437302
Virus Res. 2013 Apr;173(1):101-9
pubmed: 23159730
Arch Virol. 1991;120(3-4):207-17
pubmed: 1659798
Am J Vet Res. 1999 Aug;60(8):1022-7
pubmed: 10451216
Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):128-34
pubmed: 24099951
J Vet Med Sci. 2019 Jun 21;81(6):911-915
pubmed: 31019150
Front Immunol. 2018 Nov 12;9:2494
pubmed: 30483249
J Infect Dis. 2010 Mar 15;201(6):923-35
pubmed: 20158392
J Exp Med. 1977 Jul 1;146(1):201-17
pubmed: 406347
Viral Immunol. 1996;9(1):51-63
pubmed: 8733920
Cell Host Microbe. 2010 Sep 16;8(3):271-83
pubmed: 20833378
Injury. 2010 Oct;41(10):1012-4
pubmed: 20236639
Clin Vaccine Immunol. 2010 Dec;17(12):1829-35
pubmed: 20876821
NPJ Vaccines. 2021 Feb 1;6(1):22
pubmed: 33526776
J Exp Med. 1983 Jul 1;158(1):258-63
pubmed: 6864163
iScience. 2022 Jan 21;25(1):103720
pubmed: 35005526
Immunity. 2005 Jul;23(1):41-51
pubmed: 16039578
Rev Med Virol. 2003 Nov-Dec;13(6):387-98
pubmed: 14625886
Hum Vaccin Immunother. 2020 Dec 1;16(12):3055-3060
pubmed: 32845733
Nature. 2004 Jan 22;427(6972):313-9
pubmed: 14737159
Nature. 1977 Feb 24;265(5596):739-41
pubmed: 404559
Nat Immunol. 2019 Oct;20(10):1291-1298
pubmed: 31477918
Anal Biochem. 2020 Feb 15;591:113568
pubmed: 31881180
J Virol. 2019 Jun 28;93(14):
pubmed: 31043537
Cell. 2021 Jun 24;184(13):3452-3466.e18
pubmed: 34139176
Viruses. 2020 Feb 08;12(2):
pubmed: 32046249
J Virol. 2006 Oct;80(19):9557-68
pubmed: 16973559
Front Immunol. 2018 May 09;9:958
pubmed: 29867943
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2722-7
pubmed: 24550301
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15194-15199
pubmed: 31296560
Vet Immunol Immunopathol. 2010 Oct 15;137(3-4):317-21
pubmed: 20598755
Front Microbiol. 2022 Jul 22;13:933249
pubmed: 35935230
Vaccines (Basel). 2019 Jan 28;7(1):
pubmed: 30696015
PLoS One. 2020 Mar 3;15(3):e0229065
pubmed: 32126095
Res Vet Sci. 2016 Apr;105:47-52
pubmed: 27033907
Pathog Immun. 2018;3(1):2-18
pubmed: 29541698
Front Immunol. 2018 Oct 09;9:2322
pubmed: 30356637
Vaccine. 2018 Mar 27;36(14):1846-1852
pubmed: 29490880
J Infect Dis. 2017 Mar 1;215(5):781-785
pubmed: 28039355
Can J Microbiol. 2021 Oct;67(10):687-702
pubmed: 34171205
Vet Q. 2020 Dec;40(1):183-189
pubmed: 32448096
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211050199
pubmed: 34632844
Sci Rep. 2016 Jul 07;6:28768
pubmed: 27385443
Immunity. 2019 Sep 17;51(3):429-442
pubmed: 31533056
J Infect Dis. 1995 Sep;172(3):855-8
pubmed: 7658082
Science. 2017 Apr 14;356(6334):175-180
pubmed: 28360135
Cytometry A. 2020 Jul;97(7):662-667
pubmed: 32506725
Traffic. 2013 Jan;14(1):25-35
pubmed: 22998156
Nat Commun. 2016 Nov 22;7:13473
pubmed: 27874853
Lancet Glob Health. 2019 Aug;7(8):e988-e989
pubmed: 31201129
J Virol. 2004 Mar;78(6):3178-83
pubmed: 14990739
Immunity. 2019 Mar 19;50(3):751-762.e5
pubmed: 30737148
mSphere. 2019 Sep 18;4(5):
pubmed: 31533998
Vaccine. 2014 Jun 30;32(31):3879-82
pubmed: 24877766
J Infect Dis. 2008 May 15;197(10):1459-67
pubmed: 18444802
J Infect Dis. 2020 Nov 13;222(12):1946-1950
pubmed: 32785649
Cytokine. 2020 Dec;136:155256
pubmed: 32866898
J Virol. 2020 Feb 14;94(5):
pubmed: 31826992
J Gen Virol. 2007 Feb;88(Pt 2):365-375
pubmed: 17251552